Total
0
Shares
Little Green Pharma (ASX:LGP) - Managing Director, Fleta Solomon - The Market Herald
Managing Director, Fleta Solomon
Source: Little Green Pharma
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Little Green Pharma (LGP) has received a $2.5 million purchase order from DEMECAN for 21,300 units of its medicinal cannabis flower medicine
  • This is the fourth order DEMECAN has placed, following 500, 9000 and 17,000 units for delivery in CYQ1, CYQ2 and CYQ3, respectively
  • This new order brings DEMECAN's total orders to 47,800 units for a total cost of $5.7 million in CY21 alone
  • To capitalise on the growing demand, Little Green Pharma has brought its existing cultivation facilities to full capacity
  • Shares in Little Green Pharma are up 9.02 per cent and are trading at 66.5 cents

Little Green Pharma (LGP) has received a $2.5 million purchase order from DEMECAN for 21,300 units of its medicinal cannabis flower medicine.

Based in Germany, DEMECAN is a pharmaceutical wholesaler that covers all the manufacturing steps from cultivation, processing, storage and delivery.

This is the fourth order DEMECAN has placed, following 500, 9000 and 17,000 units for delivery in CYQ1, CYQ2 and CYQ3, respectively.

This new order brings DEMECAN's total orders to 47,800 units for a total cost of $5.7 million in CY21 alone.

To capitalise on the growing demand, Little Green Pharma has brought its existing cultivation facilities to full capacity.

Managing Director Fleta Solomon commented: "This order means a lot more than just the value of the sales it represents, it's tangible evidence of the success of our strategy."

"We are currently in a position where all flower product we produce is sold into Australia and overseas markets and we have customers looking for more.

"It heightens the urgency for us to focus on increasing our production capacity to capitalise on the brand equity we have built in the market."

Shares in Little Green Pharma are up 9.02 per cent and are trading at 66.5 cents at 2:10 pm AEST.

LGP by the numbers
More From The Market Herald
Creso Pharma (ASX:CPH) - Creso Pharma - The Market Herald

" Creso Pharma (ASX:CPH) launches ecommerce channels, enters Polish markets

Creso Pharma (CPH) has launched new e-commerce channels and expanded into Poland with a maiden purchase order secured.
Emyria (ASX:EMD) contracts consultant for psychedelics and MDMA research

" Emyria (ASX:EMD) contracts consultant for psychedelics and MDMA research

Emyria (EMD) has appointed a consultant to support its psychedelic-assisted therapy programs.
AnteoTech (ASX:ADO) - CEO, Derek Thomson - The Market Herald

" AnteoTech (ASX:ADO) ticks off another distribution deal for EuGeni

AnteoTech (ADO) has signed a distribution agreement with Ramma Dental for its EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT).
Healthia (ASX:HLA) - CEO, Wesley Coote - The Market Herald

" Healthia (ASX:HLA) up on Rothwell Physiotherapy buy

Healthia (HLA) shares have enjoyed a 10 per cent rise after reporting a $1.62 million acquisition of Queensland’s Rothwell Physiotherapy.